Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1532

BillFederalSenateIn Committee
A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
About This Bill
Committee
Latest Action · May 16, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
116th (2019–2021)
Introduced
May 16, 2019
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Pharmacy Benefit Manager Accountability Study Act of 2019 This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.